Efficacy and Safety of MBP8298 in Subjects With Secondary Progressive Multiple Sclerosis

NCT00468611 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

510

Enrollment

INDUSTRY

Sponsor class

Stopped Negative efficacy results of the MAESTRO-01 study

Conditions

Multiple Sclerosis, Secondary Progressive

Interventions

DRUG: MBP8298

Sponsor

BioMS Technology Corp.